A detailed history of Intelligence Driven Advisers, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Intelligence Driven Advisers, LLC holds 3,335 shares of DXCM stock, worth $242,888. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,335
Previous 5,099 34.6%
Holding current value
$242,888
Previous $578,000 61.42%
% of portfolio
0.03%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$64.0 - $116.06 $112,896 - $204,729
-1,764 Reduced 34.6%
3,335 $223,000
Q2 2024

Aug 05, 2024

SELL
$110.31 - $140.45 $15,112 - $19,241
-137 Reduced 2.62%
5,099 $578,000
Q1 2024

May 01, 2024

SELL
$114.22 - $140.1 $114 - $140
-1 Reduced 0.02%
5,236 $726,000
Q4 2023

Feb 06, 2024

SELL
$75.49 - $124.16 $56,994 - $93,740
-755 Reduced 12.6%
5,237 $649,000
Q3 2023

Nov 07, 2023

BUY
$86.06 - $137.93 $515,671 - $826,476
5,992 New
5,992 $559,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Intelligence Driven Advisers, LLC Portfolio

Follow Intelligence Driven Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intelligence Driven Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intelligence Driven Advisers, LLC with notifications on news.